Current assets decreased 66.1%
Current assets changed -66.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current assets changed -66.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed -64.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -79.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Capital expenditure changed -95.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +121368 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -67.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed -756 basis points from the comparable as-filed period.
Inventory / revenue changed -15915 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +17.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating income changed +23.0% from the comparable as-filed period.
SBC / revenue changed -22752 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed -83.8% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Stock-based compensation changed -63.2% from the comparable as-filed period.
Operating cash flow changed +13.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Trade receivables changed -75.3% from the comparable as-filed period.
Free-cash-flow margin changed +101688 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +78170 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
R&D / revenue changed -37793 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed -23518 basis points from the comparable as-filed period.
Current liabilities changed -22.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory changed -22.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed -56.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +2.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Research & development changed -11.4% from the comparable as-filed period.
Working capital / assets changed -1092 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Receivables / revenue changed -9816 basis points from the comparable as-filed period.
Gross profit changed -7.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.